Literature DB >> 19953370

A study of vertebrobasilar artery dissection with subarachnoid hemorrhage.

S Nakajima1, T Tsukahara, K Minematsu.   

Abstract

We retrospectively studied clinical characteristics of 368 patients with cerebral artery dissections who were diagnosed in 172 Japanese hospitals. Of these patients, 130 (35%) presented with subarachnoid hemorrhage, 217 (59%) with cerebral infarctions, and 21 (6%) with transient ischemic attacks. We analyzed 109 (84%) subarachnoid hemorrhage cases caused by vertebrobasilar artery dissection to evaluate conservative and surgical treatment from the viewpoint of postoperative rerupture and infarction.Subsequent ruptures were observed in 14% of the 21 cases with nonsurgical treatment. For the preventive purpose of rerupture, 88 patients received surgical interventions: 68 trappings, 13 proximal occlusions, 6 aneurysmal sac occlusions and 1 stenting. Rerupture was experienced in 33% of the aneurysmal sac occlusion patients while not occurring in the other three surgical interventions. In the group without vascular anastomosis, postoperative cerebral infarction was observed in 25% of the trapping, none of the proximal occlusion and 33% of the aneurysmal sac occlusion cases.In this study, aneurysmal sac occlusion treatments were more frequently complicated by rerupture or cerebral infarction postoperatively than the other treatment methods. It was difficult to determine which surgical treatment can achieve better surgical outcome among the proximal occlusion and trapping with or without vascular anastomosis.

Entities:  

Mesh:

Year:  2010        PMID: 19953370     DOI: 10.1007/978-3-211-99373-6_7

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  2 in total

Review 1.  Carotid and Vertebral Dissection Imaging.

Authors:  Hakeem J Shakir; Jason M Davies; Hussain Shallwani; Adnan H Siddiqui; Elad I Levy
Journal:  Curr Pain Headache Rep       Date:  2016-12

Review 2.  Surgical Management of Intracranial Artery Dissection.

Authors:  Koichi Arimura; Koji Iihara
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-04-11       Impact factor: 1.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.